This is the first study designed to prospectively investigate the utility of PRA and serum aldosterone levels—measured early in life (1–3 months of life)—in predicting the need for surgery due to obstructive CAKUT during follow-up. This evidence concerns the gene S100A6 and congenital anomaly of kidney and urinary tract.